Quality Assessment of Postmortem Tissue Donors in a University Hospital: Detection and Generation Tissue Indicators

Transplant Proc. 2016 Nov;48(9):2859-2861. doi: 10.1016/j.transproceed.2016.08.040.

Abstract

Background: Defining quality assessment and measurement tools in the area of tissue donation should be considered to be one of the most important strategies for developing health centers. The aim of this project was to identify, define, and analyze a set of indicators to assess the most important steps in the tissue donor detection and generation processes.

Methods: A prospective, descriptive, and comparative study of all potential tissue donors (TDs) detected and generated in a university hospital was performed. All deceased patients after cardiocirculatory death were evaluated in 2015 by the transplant coordinators (TCs). We defined as detection indicators: total deaths, percentage of detection and evaluation, percentage of clinical contraindications, tissue donor potentiality (TDP; corneal or multitissue potentiality), and the functional detection time (FDT); and as generation indicators: generation rate (corneal or multitissue generation), family request time, number of interviewed relatives, and TC experience (y).

Results: The detection and evaluation rate was 100% (n = 1,235); tissue clinical contraindications were 57%, and TDP was 43% (n = 528; corneal, 80%; multitissue, 20%). The FDT was 24 ± 30 minutes. The generation rate was 53.4% (n = 282): corneal, 57% (n = 241); and multitissue, 40% (n = 41). Family request time was 10 ± 17 minutes, average number of interviewed relatives was 2.2 ± 1.6, and 35% of TCs had experience in the field for >5 years.

Conclusions: Obtaining indicators for quality assessment in the area of tissue donation is useful in predicting the outcome of the TD process as well as promoting the approach of continuous improvement.

Publication types

  • Comparative Study

MeSH terms

  • Donor Selection / methods
  • Donor Selection / standards*
  • Female
  • Hospitals, University
  • Humans
  • Male
  • Prospective Studies
  • Quality Control*
  • Tissue Donors*
  • Tissue and Organ Procurement / standards*